First Time Loading...

Medical Data Vision Co Ltd
TSE:3902

Watchlist Manager
Medical Data Vision Co Ltd Logo
Medical Data Vision Co Ltd
TSE:3902
Watchlist
Price: 597 JPY 0.67% Market Closed
Updated: Apr 23, 2024
Section:
 

Relative Value

The Relative Value of one Medical Data Vision Co Ltd stock under the Base Case scenario is 921.96 JPY. Compared to the current market price of 597 JPY, Medical Data Vision Co Ltd is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
921.96 JPY
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.6
P/S
P/S
Price to Sales
3.6
vs History
96
vs Industry
34
Median 3Y
6.5
Median 5Y
8.3
Industry
2.4
Forward
2.8
More Details
23.3
P/E
P/E
Price to Earnings
23.3
vs History
96
vs Industry
24
Median 3Y
37.3
Median 5Y
52.2
Industry
22.8
Forward
20.5
More Details
14.1
P/OCF
P/OCF
Price to OCF
14.1
vs History
96
vs Industry
28
Median 3Y
38.5
Median 5Y
41.6
Industry
15.1
More Details
14.4
P/FCFE
P/FCFE
Price to FCFE
14.4
vs History
96
vs Industry
29
Median 3Y
40
Median 5Y
42.8
Industry
23.1
More Details
5.4
P/B
P/B
Price to Book Value
5.4
vs History
96
vs Industry
15
Median 3Y
11.1
Median 5Y
11.9
Industry
2.2
More Details
3.1
EV/S
EV/S
Enterprise Value to Sales
3.1
vs History
96
vs Industry
37
Median 3Y
6.2
Median 5Y
7.9
Industry
2.4
Forward
2.4
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
96
vs Industry
52
Median 3Y
7.5
Median 5Y
9.5
Industry
5.1
More Details
10.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.5
vs History
96
vs Industry
33
Median 3Y
20.4
Median 5Y
26.2
Industry
12.3
Forward
11.5
More Details
11.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.1
vs History
96
vs Industry
37
Median 3Y
22.1
Median 5Y
32.1
Industry
16.8
More Details
12.1
EV/OCF
EV/OCF
Enterprise Value to OCF
12.1
vs History
96
vs Industry
34
Median 3Y
36.6
Median 5Y
39.5
Industry
14.7
More Details
12.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
12.3
vs History
96
vs Industry
32
Median 3Y
37.4
Median 5Y
40.6
Industry
19.3
More Details
6.8
EV/IC
EV/IC
Enterprise Value to IC
6.8
vs History
96
vs Industry
13
Median 3Y
14.2
Median 5Y
18.1
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Medical Data Vision Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Medical Data Vision Co Ltd
TSE:3902
22.8B JPY 3.6 23.3 10.5 11.1
US
Veeva Systems Inc
NYSE:VEEV
32.7B USD 13.8 62.3 62.1 66.9
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
JP
M3 Inc
TSE:2413
1.3T JPY 5.4 27.6 14.6 16.5
AU
Pro Medicus Ltd
ASX:PME
10.9B AUD 74.4 156 107.2 107.2
US
Inspire Medical Systems Inc
NYSE:INSP
6.7B USD 10.8 -318.2 -167.5 -155.6
US
Doximity Inc
NYSE:DOCS
4.6B USD 9.9 33.7 22.8 24.3
SE
Sectra AB
STO:SECT B
41.3B SEK 25.2 97.2 -63.9 -63.9
US
Evolent Health Inc
NYSE:EVH
3.4B USD 1.7 -23.9 27.9 297.3
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD 11.7 -324 264.4 4 233.4
P/E Multiple
Earnings Growth
JP
Medical Data Vision Co Ltd
TSE:3902
Average P/E: 63.9
23.3
50%
US
Veeva Systems Inc
NYSE:VEEV
62.3
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
JP
M3 Inc
TSE:2413
27.6
26%
AU
Pro Medicus Ltd
ASX:PME
156
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -318.2 N/A
US
Doximity Inc
NYSE:DOCS
33.7
79%
SE
Sectra AB
STO:SECT B
97.2
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -23.9 N/A
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 130,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.